Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Geron Corporation - Common Stock (NQ:GERN)

1.240 -0.010 (-0.80%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,462,770
Open 1.250
Bid (Size) 1.230 (1,200)
Ask (Size) 1.240 (1,800)
Prev. Close 1.250
Today's Range 1.230 - 1.280
52wk Range 1.040 - 4.255
Shares Outstanding 508,766,846
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Geron Corp (NASDAQ:GERN) Reports Mixed Q3 2025 Results, Misses Revenue Estimates
Geron's Q3 2025 results show mixed performance, with RYTELO revenue up 67% year-over-year but missing analyst sales estimates, causing a negative market reaction. 
Via Chartmill
Geron Corporation Reports Third Quarter 2025 Financial Results and Recent Business Highlights
From Geron Corporation
Via Business Wire

Performance

YTD
-65.6%
-65.6%
1 Month
-2.4%
-2.4%
3 Month
-8.1%
-8.1%
6 Month
+3.3%
+3.3%
1 Year
-69.9%
-69.9%

More News

Read More
Earnings Scheduled For November 5, 2025
Via Benzinga
Geron Earnings Preview
Via Benzinga
Geron Corporation to Present at Upcoming Investor Conferences
From Geron Corporation
Via Business Wire
Earnings Scheduled For August 6, 2025
Via Benzinga
Geron Corporation Announces Five Presentations Selected for ASH 2025 Highlighting Clinical Activity of RYTELO® (imetelstat) in Myeloid Hematologic Malignancies
From Geron Corporation
Via Business Wire
Geron Plans to Announce Third Quarter 2025 Financial Results on November 5, 2025
From Geron Corporation
Via Business Wire
GERON (GERN) INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Geron Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
Geron to Participate in the 2025 Wells Fargo Healthcare Conference
From Geron Corporation
Via Business Wire
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
GERON (GERN) ALERT: Bragar Eagel & Squire, P.C. is Investigating Geron Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
Geron (GERN) Q2 Revenue Jumps 5,477%
Via The Motley Fool
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Geron Corporation Reports Second Quarter 2025 Financial Results and Recent Business Highlights
From Geron Corporation
Via Business Wire
Geron Appoints Harout Semerjian as President and Chief Executive Officer
From Geron Corporation
Via Business Wire
Geron Plans to Announce Second Quarter 2025 Financial Results on August 6, 2025
From Geron Corporation
Via Business Wire
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
Geron Announces Presentations at ASCO and EHA Underscoring RYTELO® (imetelstat) Efficacy and Safety Across Range of LR-MDS Patients, and Showcasing Momentum of Myelofibrosis Program
From Geron Corporation
Via Business Wire
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
GERON ALERT: Bragar Eagel & Squire, P.C. is Investigating Geron Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Geron
From Faruqi & Faruqi, LLP
Via Business Wire

Frequently Asked Questions

Is Geron Corporation - Common Stock publicly traded?
Yes, Geron Corporation - Common Stock is publicly traded.
What exchange does Geron Corporation - Common Stock trade on?
Geron Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Geron Corporation - Common Stock?
The ticker symbol for Geron Corporation - Common Stock is GERN on the Nasdaq Stock Market
What is the current price of Geron Corporation - Common Stock?
The current price of Geron Corporation - Common Stock is 1.240
When was Geron Corporation - Common Stock last traded?
The last trade of Geron Corporation - Common Stock was at 11/12/25 04:00 PM ET
What is the market capitalization of Geron Corporation - Common Stock?
The market capitalization of Geron Corporation - Common Stock is 630.87M
How many shares of Geron Corporation - Common Stock are outstanding?
Geron Corporation - Common Stock has 631M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.